This Consortium serves as the review committee for the Diversity Supplement Program. Below is a list of the current members.
| Name | Area(s) of Expertise | Phone |
|---|---|---|
|
Pamela Goodlow (Chair) |
Ethnic/minority issues, research training and career development |
301-435-0925 |
|
Drug abuse treatment research, treatment research in community settings, treatment of pain |
301-443-3207 |
|
|
Ethnic populations (Hispanic/Latino and Asian American and Pacific Islander) |
301-443-0441 |
|
|
Grant management issues |
202-722-4093 |
|
|
Pharmacology; neuroscience; AIDS |
301-402-1972 |
|
|
Neuroplasticity and neurotoxicology; methamphetamine; marijuana; hallucinogens |
301-435-1312 |
|
|
Treatment and Intervention Services for HIV/AIDS; gender differences; co-occurring disorders |
301-402-1984 |
|
|
Medical consequences of drug abuse and co-occurring infections; clinical molecular biology; immunology; neuroscience |
301-443-1061 |
|
|
Prenatal/perinatal exposure; maternal/fetal pharmacokinetics; pain/analgesia; physiological systems |
301-594-5753 |
|
|
Prevention; early interventions; preadolescent and adolescent drug abuse and HIV prevention; methodology research |
301-402-1533 |
|
|
Grants management issues |
410-254-1853 |
Attention
Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at
Looking for Treatment?
Use the SAMHSA Treatment Locator or 1-800-662-HELP.
Helpline open during government shutdown
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.